MAPT and Alzheimer disease: Abnormal aggregation of proteins such as β-amyloid, tau, α-synuclein and polyglutamine-containing proteins is known to be related to the pathology of neurodegenerative diseases including Alzheimer’s disease (AD), Parkinson’s disease (PD) and Huntington’s disease (HD) [5,6,7].